======= NCAPG2 ======= == Gene Information == * **Official Symbol**: NCAPG2 * **Official Name**: non-SMC condensin II complex subunit G2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54892|54892]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86XI2|Q86XI2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NCAPG2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NCAPG2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608532|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that belongs to the Condensin2nSMC family of proteins. The encoded protein is a regulatory subunit of the condensin II complex which, along with the condensin I complex, plays a role in chromosome assembly and segregation during mitosis. A similar protein in mouse is required for early development of the embryo. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis. {ECO:0000269|PubMed:14532007}. |Condensin2nSMC| |molecular function regulator| |condensin complex| |negative regulation of erythrocyte differentiation| |inner cell mass cell proliferation| |blastocyst growth| |bHLH transcription factor binding| |positive regulation of signaling receptor activity| |chromosome condensation| |regulation of erythrocyte differentiation| |positive regulation of protein tyrosine kinase activity| |methylated histone binding| |negative regulation of myeloid cell differentiation| |erythrocyte differentiation| |erythrocyte homeostasis| |regulation of protein tyrosine kinase activity| |blastocyst development| |myeloid cell homeostasis| |negative regulation of hemopoiesis| |regulation of signaling receptor activity| |DNA packaging| |positive regulation of peptidyl-tyrosine phosphorylation| |homeostasis of number of cells| |myeloid cell differentiation| |regulation of myeloid cell differentiation| |regulation of peptidyl-tyrosine phosphorylation| |DNA conformation change| |in utero embryonic development| |developmental growth| |growth| |nuclear speck| |negative regulation of immune system process| |regulation of hemopoiesis| |transcription by RNA polymerase II| |cell division| |positive regulation of protein kinase activity| |cell population proliferation| |hemopoiesis| |positive regulation of kinase activity| |hematopoietic or lymphoid organ development| |chordate embryonic development| |transcription, DNA-templated| |nucleic acid-templated transcription| |immune system development| |embryo development ending in birth or egg hatching| |RNA biosynthetic process| |positive regulation of transferase activity| |negative regulation of cell differentiation| |regulation of protein kinase activity| |regulation of kinase activity| |negative regulation of developmental process| |regulation of transferase activity| |embryo development| |positive regulation of protein phosphorylation| |positive regulation of phosphorylation| |chromosome organization| |nucleobase-containing compound biosynthetic process| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |organic cyclic compound biosynthetic process| |cell cycle| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |cellular nitrogen compound biosynthetic process| |homeostatic process| |regulation of immune system process| |RNA metabolic process| |positive regulation of protein metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of protein modification process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp505|ML-792 0.2μM R08 exp505]]|-2.29| |[[:results:exp11|CCCP 1μM R00 exp11]]|-2.18| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|-2.12| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.88| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|-1.86| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|-1.76| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.75| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.75| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.74| |[[:results:exp539|42°C R08 exp539]]|1.75| |[[:results:exp93|DABN racemic mixture R03 exp93]]|2.04| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 441/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|22/28| |blood|19/28| |bone|15/25| |breast|19/33| |central nervous system|35/56| |cervix|0/4| |colorectal|9/17| |esophagus|8/13| |fibroblast|1/1| |gastric|10/15| |kidney|17/21| |liver|11/20| |lung|54/75| |lymphocyte|4/14| |ovary|14/26| |pancreas|13/24| |peripheral nervous system|6/16| |plasma cell|5/15| |prostate|0/1| |skin|20/24| |soft tissue|3/7| |thyroid|1/2| |upper aerodigestive|11/22| |urinary tract|12/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2662 * **Expression level (log2 read counts)**: 7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}